This marked enhancement in efficacy suggests synergistic interaction between mitochondrial translation inhibition and HDAC inhibition in patient-derived models that more accurately recapitulate tumor heterogeneity and microenvironment than conventional cell lines. Here, HDAC9 is linked to neoplasm.